Objectives: To evaluate the presence of qnr genes among enterobacterial isolates carrying extendedspectrum b-lactamases (ESBLs) in Barcelona, Spain.
Introduction
In 1998, the first plasmid-mediated quinolone resistance (Qnr) was reported, in a Klebsiella pneumoniae isolate. 1 Qnr proteins belong to the pentapeptide repeat family and are able to bind to DNA gyrase and topoisomerase IV, protecting them from the inhibitory activity of quinolones. 2 The first Qnr detected, a protein of 218 amino acids, was named QnrA. Since then, two more Qnr determinants have been described, QnrB and QnrS, which share 40% and 59% amino acid identity, respectively, with QnrA. 3 Qnr has been detected in several members of the Enterobacteriaceae family, mainly in K. pneumoniae, Escherichia coli and Enterobacter spp., in different countries. 2 Plasmids harbouring qnr may also carry extended-spectrum b-lactamasesz (ESBLs). 3 -5 The aim of this study was to evaluate the presence of qnr genes among enterobacterial isolates carrying ESBLs in our area. 
Materials and methods

Bacterial isolates
Antimicrobial susceptibility testing
Susceptibility to antimicrobials was determined by disc diffusion, following the CLSI recommendations. Suggestive evidence of ESBL production was defined as synergy between amoxicillin/clavulanate and at least one of the following antibiotics: cefotaxime, ceftazidime, aztreonam or cefepime, and confirmed by the Etest ESBL strip (AB Biodisk, Solna, Sweden). Nalidixic acid and ciprofloxacin MICs were determined using Etest (AB Biodisk).
PCR amplification and sequencing
Screening for the qnrA, qnrB and qnrS genes was carried out by PCR amplification using specific primers (Table 1 ). All positive results were confirmed by direct sequencing of both strands of amplicons. The quinolone-resistance-determining region (QRDR) of the gyrA and parC genes was sequenced directly from PCR-amplified DNA.
Characterization of ESBLs
ESBLs of all qnr-positive isolates were characterized further by isoelectric focusing. On the basis of these results, PCR amplification and DNA sequencing of different bla genes were done using specific primers (Table 1) .
Plasmid DNA analysis
Plasmid number and sizing was performed on all qnr-positive isolates by S1 nuclease digestion as previously described. 6 PFGE gels were transferred onto positively charged nylon membranes and hybridized with specific probes for qnrA1, qnrS1, bla CTX-M-9 and bla SHV-12/92 obtained by PCR with primers mentioned above.
Transfer of quinolone resistance
Conjugation experiments involving the qnr-positive isolates were performed by the liquid mating assay as previously described, 6 using a rifampicin-resistant derivative of E. coli HB101 as the recipient isolate and selecting on LB agar supplemented with 100 mg/L rifampicin, 3 mg/L nalidixic acid and/ or 100 mg/L ampicillin.
The plasmid DNA of the qnrS-positive isolates and of the isolates for which no transconjugants were obtained was electroporated into the kanamycin-resistant E. coli AG100A 
Cloning experiments
On selected isolates, the region surrounding qnr was cloned by ligating HindIII-digested total DNA fragments into the vector pBC-SKþ (Stratagene, La Jolla, CA, USA). DNA sequencing was carried out with a series of outward-facing primers starting from both ends of the qnr gene.
Molecular typing
To elucidate the clonality of qnr-carrying isolates, PFGE analysis of XbaI-digested DNA was done as previously described. 6 Clonal relationship of the isolates that could not be typed by PFGE was assessed by studying ERIC-PCR genomic DNA profiles, as generated using primers ERIC1 and ERIC2 (Table 1) .
Nucleotide sequence accession number
The described sequences for SHV-92, pQKp274H and pQKp331H have been assigned GenBank accession numbers DQ836922, EF682136 and EF682137, respectively.
Results and discussion
Fifteen out of the 305 isolates studied, each from a different individual, carried qnr (4.9%). Among the qnr-positive isolates, 14 had qnrA1 (6 K. pneumoniae, 6 E. cloacae and 2 E. coli isolates) and one had qnrS1 (K. pneumoniae). No isolate carried qnrB ( Table 2) . Among the total isolates studied, 39.7% and 69.2% were susceptible to nalidixic acid and ciprofloxacin, respectively. Four of the 15 qnr-positive isolates (26.7%) were nalidixic acid-resistant, with MICs ranging from 32 to 256 mg/L, and one was of Among the 14 qnrA1-carrying isolates, 10 possessed both bla CTX-M-9 and bla SHV-12 , 2 both bla CTX-M-9 and bla SHV-92 , a novel SHV variant which showed three amino acid changes compared with SHV-1 (Leu-35!Gln, Met-69!Ile, Thr-141!Ile; pI 7.6; SHV number assigned by G. A. Jacoby, Lahey Clinic, MA, USA, personal communication), and 2 bla CTX-M-9 alone. The isolate with qnrS1 possessed bla SHV-12 and a bla gene, which shares 100% identity with the bla gene found in pK245 and differs in only one amino acid (Gly-193!Glu) from the recently described bla LAP-1 . 4, 7 No bla TEM b-lactamase was found in any of the qnr-positive isolates.
Plasmid analysis of all qnr-positive isolates showed that qnrA1 was located in plasmids ranging in size from 40 to 320 kb ( Table 2 ). All but 1 of the 14 qnrA1-positive isolates harboured ESBL genes and qnrA1 located in the same plasmid. In the remaining qnrA1-positive isolate (K. pneumoniae 331), bla CTX-M-9 was located in a plasmid of 250 kb, whereas bla SHV-12 and qnrA1 were present together on a different plasmid of 40 kb. K. pneumoniae 529 carrying qnrS1 was not possible to digest with S1 nuclease because of DNA self-degradation.
Conjugation experiments involving the qnr-positive isolates revealed that Qnr was successfully transferred from all but three qnr-positive donor isolates (Table 2) . No transformants were obtained after electroporation of the plasmid DNA from those isolates for which no transconjugants were obtained. Transconjugants carrying qnrA1 also carried bla CTX-M-9 and bla SHV-12/92. Transconjugants carrying qnrS1 did not possess bla SHV-12 .
qnrA1 variants are typically found in a sul1-type integron that contains ISCR1 upstream of the qnr gene and either qacED1-sul1 or ampR-qacED1-sul1 downstream. 3 Analysis of the regions surrounding qnrA1 by PCR showed that all isolates had ISCR1 immediately upstream of qnrA1 and all but two isolates (K. pneumoniae 274 and K. pneumoniae 331) had an ampR gene between qnrA1 and qacED1-sul1.
The region surrounding qnrA1 in K. pneumoniae 274 and K. pneumoniae 331 cloned by ligating HindIII-digested total DNA fragments into the vector pBC-SKþ resulted in recombinant qnrA1 plasmids pQKp274H and pQKp331H, respectively. Sequence analysis of these constructs revealed that the ampR gene, located downstream of qnrA1, was truncated by a composite transposon consisting of two inverted repeat IS26 elements flanking a tetR and a tetA gene [ Figure S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)].
qnrS1 has been described downstream of two different structures, including: (i) a Tn3 element which contains bla TEM-1 ; and (ii) bla LAP-1 . 4, 7, 8 DNA sequence analysis of a 5 kb region surrounding qnrS1 revealed 100% identity with qnrS1-containing plasmid pK245, including the bla LAP -like gene. However, unlike pK245, the present plasmid harbouring qnrS1 did not contain a bla SHV-2 gene and could be self-transferred by conjugation (Table 2) . PFGE analysis of XbaI-digested DNA of the qnr-positive isolates showed that all the E. cloacae isolates had a different PFGE pattern. The two E. coli were obtained from two brothers and shared the same PFGE profile. Likewise, two K. pneumoniae isolates had the same PFGE profile. These isolates had been obtained from different patients who shared the same paediatric intensive care unit room. K. pneumoniae isolate 529 could not be typed by PFGE because of DNA self-degradation; however, by ERIC-PCR it showed a different pattern from the other K. pneumoniae isolates, suggesting a unique clonal background (data not shown) ( Table 2) .
In this work, four qnr-positive isolates were resistant to nalidixic acid. Two of these exhibited high-level resistance (MIC 256 mg/L) presumably due to the associated mutation in the QRDR of gyrA and two isolates exhibited low-level resistance (MIC 32 mg/L) Regarding ciprofloxacin, all isolates except one were susceptible, but showed decreased susceptibility compared with those isolates without any resistance mechanism. Moreover, the two isolates with the highest MICs of ciprofloxacin were those with mutations in the QRDR. These data agree with previous reports showing that the presence of qnr does not necessarily lead to MICs above CLSI breakpoints for resistance to ciprofloxacin. 1 The basis for concern regarding the low-level resistance conferred by this mechanism remains the increment this causes in the selection window to high-level quinolone resistance.
9
Our results differ from those of a recent Spanish study where 11% of 202 Enterobacter spp. clinical isolates carried qnrS but none carried qnrA.
10 However, our results are similar to those of a recent report in France, which showed that, in a collection of 186 ESBL-producing bacteria obtained from 2002 to 2005 in a hospital in Paris, 2.2% and 1.6% of the isolates carried qnrA1 and qnrS1 (qnrB was not evaluated), respectively. 5 Our findings show that in our locale qnr variants are variably prevalent among ESBL-producing enterobacterial and are associated with reduced quinolone susceptibility in the absence of other explanatory mechanisms. Further studies in more heterogeneous bacterial populations are necessary to comprehensively assess the prevalence of Qnr and its clinical significance.
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